BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
MBI
MBIA Inc.
There isn't enough reported data to score MBI yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MBI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
MBI's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like MBI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
MBI PE Valuation
MBI has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
MBI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| -- | |
| Limited | |
| Moderate |
Analysts expect MBI's losses to shrink, with revenue declining.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MBI on earnings quality, reporting a profit while its opponent remains loss making.
MBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.21 | +$0.43 |
| Q2 2026 | -$2.89 | +$1.76 |
| Q1 2026 | -$3.10 | +$5.78 |
| Q4 2025 | -$3.58 | +$5.86 |
| Q3 2025 | -$3.64 | +$7.44 |
| Q2 2025 | -$4.65 | +$9.19 |
| Q1 2025 | -$8.88 | +$1.07 |
| Q4 2024 | -$9.44 | +$0.53 |
MBI is still losing money, but far less than before: $3.21 per share over the past year, against $13.84 at its worst in mid-2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over MBI on profitability, with a higher operating margin.
MBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26M | +73% |
| Q2 2026 | $27M | +17% |
| Q1 2026 | $24M | +71% |
| Q4 2025 | $28M | -24% |
| Q3 2025 | $15M | -48% |
| Q1 2025 | $14M | +7.7% |
| Q3 2024 | $29M | +263% |
| Q1 2024 | $13M | +550% |
MBI's revenue is recovering but still below its 2020 peak: $26M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -88% | -42 points |
| Q2 2026 | -159% | +84 points |
| Q1 2026 | -171% | +272 points |
| Q4 2025 | -200% | -65 points |
| Q3 2025 | -47% | +129 points |
| Q2 2025 | -243% | N/A |
| Q1 2025 | -443% | +226 points |
| Q4 2024 | -135% | N/A |
MBI's operating margin was −88% last quarter, down 42 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over MBI on cash generation, producing positive trailing cash flow while its opponent burns cash.
MBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$73M | -181% |
| Q2 2026 | -$4M | -500% |
| Q1 2026 | -$33M | +$10M |
| Q4 2025 | -$10M | -433% |
| Q3 2025 | $90M | +$229M |
| Q2 2025 | $1M | +$11M |
| Q1 2025 | -$43M | -$13M |
| Q4 2024 | $3M | +$5M |
MBI's free cash flow was −$120M over the past year, against $51M the year before. Free cash flow isn't a meaningful measure for financial services companies like MBI.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +64.9K shares |
| 1 year | +1.3% | +665K shares |
| 3 years | +6.9% | +3.3M shares |
| 5 years | +1.4% | +710K shares |
| Available history | -38% | -30.8M shares |
MBI has 50M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $1M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $7M |
| Q4 2024 | — |
MBI spent $1M buying back its own shares over the past year, down 86% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MBI Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 33.3 | Neutral |
MBI's weekly RSI is 40 (neutral) and its Stochastic is 33 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
MBI PE vs Financial Services Sector
MBI has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.49 | 4.2% above |
| 20 week MA | $5.01 | 6.6% below |
| 50 week MA | $5.82 | 20% below |
| 100 week MA | $5.88 | 20% below |
| 200 week MA | $6.60 | 29% below |
MBI has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 29% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over MBI on returns for 2026, with the stronger performance.
MBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.26 | $6.95 | -25% |
| 2021 | $6.95 | $12.4 | +79% |
| 2022 | $12.4 | $12.9 | +3.7% |
| 2023 | $12.9 | $6.12 | -53% |
| 2024 | $6.12 | $6.10 | -0.3% |
| 2025 | $6.10 | $7.12 | +17% |
| 2026 YTD | $7.12 | $4.68 | -34% |
MBI has finished lower in three of the last six years. It's down 34% so far in 2026.